Cem Küçükerdönmez

Cem Küçükerdönmez

Auto-generated profile, based on publicly available information

Cem Küçükerdönmez

Department of Ophthalmology, Baskent University School of Medicine, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2009 in Eye
Verified
Journal Article
Closed access
CKC Kucukerdonmez
C Kucukerdonmez
AKA Karalezli
A Karalezli
YAY A Akova
Y A Akova
MBM Borazan
M Borazan

13 March 2015 in Eye
Verified
Journal Article
Closed access
ECE Cinar
E Cinar
MZM O Zengin
M O Zengin
CKC Kucukerdonmez
C Kucukerdonmez

1 January 2008 in Ocular Immunology and Inflammation
Verified
Journal Article
Closed access
CKCem Küçükerdönmez
Cem Küçükerdönmez
YAYonca A. Akova
Yonca A. Akova
GYGürsel Yilmaz
Gürsel Yilmaz
Purpose: To report a case of presumed Eales disease that showed regression of retinal neovascularization after the use of intravitreal bevacizumab. Design: Retrospective, interventional case report. Methods: Broad retinal neovascularization in a patient with presumed Eales disease did not regressed despite adequate photocoagulation treatment, and bevacizumab (1.25 mg) was injected intravitreally. The patient was followed up for 1 year. Results: One week after injection, fluorescein angiography demonstrated dramatic regression of retinal neovascularization. After 12-months, visual acuity was improved and no signs of recurrence were observed. Conclusion: Intravitreal bevacizumab may be effective as an adjunctive treatment of retinal neovascularization in patients with Eales disease.

1 January 2021 in Turkish Journal of Ophthalmology
Verified
Journal Article
Open access
RARemzi Avcı
Remzi Avcı
AYAyşegül Mavi Yıldız
Ayşegül Mavi Yıldız
EÇEsat Çınar
Esat Çınar
SYSami Yılmaz
Sami Yılmaz
CKCem Küçükerdönmez
Cem Küçükerdönmez
EAEmre Avcı
Emre Avcı
To evaluate the functional and morphological outcomes of vitrectomy in combination with intravitreal 5% C3F8 tamponade and subretinal injections of tissue plasminogen activator (tPA) and anti-vascular endothelial growth factor (anti-VEGF) in patients with submacular hemorrhage (SMH) and to investigate the preoperative prognostic factors. This retrospective study included 30 patients (16 women, 14 men) diagnosed with SMH secondary to neovascular age-related macular degeneration (AMD). Preoperative SMH thickness and area, ellipsoid zone integrity, and postoperative reduction in the amount of subfoveal blood on optical coherence tomography and fundus photographs were assessed. Furthermore, visual acuity (VA), hemorrhage duration, and the need for additional intravitreal anti-VEGF injections were recorded. The patients' mean age was 73.33±8.23 years. Mean VA improved from logMAR 2.11±0.84 at baseline to logMAR 1.32±0.91, 0.94±0.66, 1.13±0.84, and 1.00±0.70 at postoperative month 1, 2, 3, and 6, respectively. A significant negative correlation was found between hemorrhage duration and postoperative VA at month 2 (p=0.005), month 3 (p=0.019), and month 6 (p=0.012). The mean preoperative SMH duration was significantly shorter in patients who achieved total resolution of the hemorrhage compared with the subtotal resolution group (p<0.001). The mean SMH area was smaller in the patients with continuous ellipsoid zone. Vitrectomy and submacular tPA and anti-VEGF injections with concurrent C3F8 tamponade appears to provide adequate displacement of the hemorrhage, resulting in significant VA improvement in patients with hemorrhagic neovascular AMD. Timing of the surgery appears to be the most important factor determining the final VA.

23 May 2014 in Ophthalmic Surgery, Lasers and Imaging Retina
Verified
Journal Article
Closed access
PDF file
MZMehmet Özgür Zengin
Mehmet Özgür Zengin
TÖTolga Öz
Tolga Öz
ABAyşegül Baysak
Ayşegül Baysak
EÇEsat Çinar
Esat Çinar
CKCem Küçükerdönmez
Cem Küçükerdönmez
BACKGROUND AND OBJECTIVE: To evaluate choroidal thickness using spectral-domain optical coherence tomography (SD-OCT) in patients with obstructive sleep apnea syndrome (OSAS) in comparison to healthy controls. PATIENTS AND METHODS: This observational, comparative study consisted of 35 patients with OSAS and 32 age- and sex-matched controls. The controls did not have systemic or ocular diseases. All study participants underwent complete ophthalmic examination as well as choroidal thickness measurement using a high-speed, high-resolution SD-OCT device. RESULTS: The mean horizontal and vertical choroidal thicknesses, respectively, were 237.84 ± 69.9 μm and 234.97 ± 62.0 μm ( P = .654) in patients with OSAS and 244.09 ± 41.2 μm and 241.88 ± 40.9 μm ( P = .590) in the healthy controls. The mean choroidal thicknesses were thinner in patients with OSAS, but the difference was not significant ( P > .05 for all values). CONCLUSION: No differences in choroidal thickness were found between patients with OSAS and healthy controls. [ Ophthalmic Surg Lasers Imaging Retina . 2014;45:298–304.]

1 February 2007 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
CKCem Küçükerdönmez
Cem Küçükerdönmez
YAYonca A. Akova
Yonca A. Akova
DADilek Dursun Altinörs
Dilek Dursun Altinörs